Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 14.03.2025
https://research-hub.de/companies/cyan AG
cyan AG reported strong preliminary 2024 results, with revenue increasing 50% yoy to EUR 7.1m, aligning with the upper half of guidance. Growth was driven by an 86% expansion in the subscriber base, while EBITDA losses narrowed significantly from EUR -4.5m to EUR -1.6m to -1.5m, supported by cost optimizations and the sale of the OSS/BSS business. For 2025, cyan targets EUR 8.4 - 9.2m in revenue and break-even EBITDA, supported by continued telecom expansion. While mwb research’s short-term growth expectations have been adjusted due to a mix of factors, such as slower new product ramp-up and customer onboarding delays in the telecom business, the analysts see stronger mid-to-long-term potential, partially offsetting downward revisions in their model. mwb research’s analysts reiterate their BUY rating with a revised price target of EUR 3.65 (previously EUR 3.85). The full update can be downloaded under https://www.research-hub.de/companies/cyan%20AG
Fri, 14.03.2025
https://research-hub.de/companies/Enapter AG
Enapter is expanding its product offering by integrating battery solutions from its joint venture with Wolong Group, which improves energy stability, optimizes hydrogen production, and enhances renewable energy utilization. Furthermore, the management has recently increased its stake in the company, signaling insider confidence, particularly in light of the challenging hydrogen market conditions. This move reflects management's commitment to the company’s long-term success, which mwb research’s analysts see as a reassuring signal. Despite current market challenges, Enapter’s solid order intake and low Price/Book ratio of 1.3x make its shares an attractive investment. The analysts maintain their Spec. BUY rating with an unchanged PT of EUR 7.00 based on cautious estimates. For firsthand insights from the CEO and CFO, register for the online roundtable March 19, here: https://research-hub.de/events/registration/2025-03-19-14-00/H2O-GR. The full update can be downloaded under https://www.research-hub.de/companies/Enapter%20AG
Fri, 14.03.2025
Scandinavian Astor Group AB
Company Name:
Scandinavian Astor Group AB
ISIN:
SE0019175274
Reason for the research:
Update
Recommendation:
Buy
from:
14.03.2025
Target price:
SEK 30.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Scandiflash in full swing; stock back at BUYing levels
Topic: Astor announced another strong [ … ]
Fri, 14.03.2025
https://research-hub.de/companies/Circus SE
Circus SE has announced the appointment of Kasper Rørsted to its Board of Advisors, further strengthening its leadership as the company scales its autonomous food production systems. Rørsted, a highly accomplished executive with extensive experience in global business transformation, previously led Adidas (2016–2022) and Henkel (2008–2016) as CEO and held senior roles at Hewlett-Packard, Compaq, and Oracle. His strategic expertise in technology and operational excellence is expected to be instrumental in Circus’ global expansion. Today’s press release marks the second high-profile addition to Circus’ roster, following the appointment of Claus Holst-Gydesen as Co-CEO in February. First significant revenues expected in H2 should boost confidence in Circus’ ability to disrupt the global foodservice industry. mwb research’s analysts reiterate to BUY with a EUR 75.00 target price. For a recent first-hand update, please see the recording of the recent roundtable with the management here: https://researchhub.de/events/video/2025-02-05-13-30/CA1-GR. The full update can be downloaded under https://research-hub.de/companies/circus-se
Fri, 14.03.2025
ASMALLWORLD AG
Company Name:
ASMALLWORLD AG
ISIN:
CH0404880129
Reason for the research:
Update
Recommendation:
Buy
from:
14.03.2025
Target price:
CHF 2.80
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
FY'24 out, focus on member growth; chg. est & PT
Topic: ASW reported mixed FY'24 results and provided a [ … ]
Fri, 14.03.2025
Flughafen Wien AG
Company Name:
Flughafen Wien AG
ISIN:
AT00000VIE62
Reason for the research:
Update
Recommendation:
Hold
from:
14.03.2025
Target price:
EUR 60.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Summer flight plan with strong demand & Feb' traffic results
Topic: Yesterday, FWAG published a su [ … ]
Fri, 14.03.2025
MLP SE
Company Name:
MLP SE
ISIN:
DE0006569908
Reason for the research:
Update
Recommendation:
Buy
from:
14.03.2025
Target price:
EUR 13.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Q4 in line; dividend and new mid-term targets out; chg. est & PT
Q4 in line: Q4 total sales stood at € 30 [ … ]
Thu, 13.03.2025
https://research-hub.de/companies/Wacker Chemie AG
Wacker Chemie reported detailed Q4 and 2024 numbers that were in line with its preliminary release. Topline in Q4 and 2024 declined yoy and fell short of consensus, mainly due to weaker volumes, while 2024 EBITDA of EUR 763m (-7% yoy; Q4 EBITDA: +106% yoy, aided by one-offs) beat consensus of EUR 735m, with yoy decline was weighed down by high energy costs and scaled-back production. Despite these challenges, the chemicals business, including Silicones and Polymers, showed some resilience, while Biosolutions delivered impressive growth. Polysilicon, however, remained a drag, hit by weak solar-grade demand and Chinese oversupply. Looking ahead, mwb research’s analysts believe Wacker is well-positioned to navigate near-term headwinds through its cost-saving initiatives and strategic investments in high-margin specialty chemicals and semi polysilicon. The analysts expect 2025 to be a mixed but gradually improving year. Consequently, mwb research remains conservative in their estimates. With stock trading at attractive valuation levels, offering a favorable risk-reward profile, the analysts maintain their BUY rating with a revised PT of EUR 95.00. The full update can be downloaded under https://www.research-hub.de/companies/Wacker%20Chemie%20AG
Thu, 13.03.2025
https://research-hub.de/companies/Brenntag SE
Brenntag reported decent set of numbers in Q4 2024 with flat yoy sales in constant currencies (c.c.), and an operating (op.) gross profit growth of 1% yoy c.c., 1% ahead of consensus. However, volume-driven cost increases and inflationary pressure weighed on op. EBITA, dragging it down 9% yoy in c.c. to EUR 264m, 5% below consensus. In FY 2024, sales declined 3% yoy in c.c. to EUR 16.24bn and op. EBITA was down 13% yoy to EUR 1.1bn, ending at the lower end of its guidance range. Management expects depressed consumer sentiment, economic uncertainties, together with competition from Chinese imports, to prolong recovery. It guides for modest improvement in volumes and slightly better qoq pricing trends and op. EBITA to reach EUR 1.1bn-1.3bn (+9% yoy at the mid-point) in FY 25. On the strategy front, Brenntag continues to invest in cost containment programmes and is carrying out targeted segment disentanglement. These should help the company capitalize on emerging opportunities as markets regain momentum. mwb research’s analysts maintain their BUY rating with a new PT of EUR 79.00. The full update can be downloaded under https://www.research-hub.de/companies/Brenntag%20SE
Thu, 13.03.2025
https://research-hub.de/companies/Puma SE
Puma’s Q4 2024 results were in line with prelims, Q4 sales rising 16% yoy (+10% c.a.) to EUR 2.29bn, driven by broad-based growth across regions and channels. However, despite a 15% EBIT increase to EUR 109m, margins remained flat at 4.8%. FY24 saw moderate 3% revenue growth, but management’s cautious FY25 guidance—projecting low-to-mid single-digit sales growth and an EBIT range of EUR 520m-600m—fell short of consensus. Puma aims to restore profitability through its "nextlevel" program, focusing on product simplification and cost control, targeting an EBIT margin of 8.5% by 2027. With the stock down ~50% YTD, valuation appears attractive, prompting a reiterated BUY rating at a lower PT of EUR 35.00 (old: EUR 50.00) after mwb research’s analysts trimmed their EBIT trajectory to reflect a slower recovery. The full update can be downloaded www.research-hub.de/companies/research/Puma%20SE